One page, thousands of outlets. See who else covered it.
The Federal Reserve’s reluctance to tighten monetary policy after a prolonged period of above-target inflation is keeping long-term bond yields at multiyear highs, posing a broader risk to markets, according to Citadel Securities.
We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.
Eurofarma has partnered with Japan's Eisai to sell the insomnia drug lemborexant (Dayvigo) in Brazil, targeting a market worth about US$240 million a year.
Tom Lee’s Ethereum treasury company keeps buying the second-biggest crypto through the downturn, while more than 5 million staked ETH is projected to generate $287 million in annual rewards.
The Pound Sterling registers modest gains of 0.14% on Monday as investors digest softer-than-expected US inflation data and brace for the release of crucial UK jobs and inflation data.